In the following, we will focus on specific lung cancer mutations in proto-oncogenes (KRAS, EGFR, ALK, MYC) and tumor suppressor genes (p53, LKB1) and how they relate to alterations in the TME. The gene discussed is KRAS; the disease is lung carcinoma.